REMI.OB on OTC BB

0.45USD
9 Feb 2010
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.45
Open
--
Day's High
$0.45
Day's Low
$0.35
Volume
10,200
Avg. Vol
6,850
52-wk High
$0.94
52-wk Low
$0.20

view people for:

Summary

Name Age Since Current Position
De Vreese, Guy 54 2008 Chairman of the Board, Chief Executive Officer
Ross, Stephen 50 2008 Chief Financial Officer, Secretary, Director
Van Acker, Philippe 44 2008 Chief Accounting Officer, Director
Kolsteeg, Fred 66 2002 Director
» Insider Trading

Biographies

Name Description
De Vreese, Guy Mr. Guy De Vreese is the Chairman of the Board and Chief Executive Officer of Remedent, Inc. From April 1, 2002, Mr. De Vreese has served as Chairman of the Board. Effective upon Mr. List’s resignation as Chief Executive Officer, on December 10, 2008 Mr. De Vreese became Chief Executive Officer. From June 2001 Mr. De Vreese has also served as President of Remedent N.V. and he has served as President of DMDS, Ltd., a European subsidiary of Dental & Medical Systems, Inc. DMDS, Ltd. developed and marketed high-tech dental equipment. In August 1996, Mr. De Vreese founded DMD N.V., a Belgian company that was the independent European distributor for DMDS products and was its Chief Executive Officer until DMD purchased its distribution rights in April 1998. Mr. De Vreese later worked as CEO from 1996 through February 1999 for Lident, N.V., a Belgian company that merged with DMD and specialized in digital photography and developer of imaging software. Mr. De Vreese also served as a consultant providing services to DMDS, Ltd. from February 1999 to June 2001. Mr. De Vreese resides in Belgium.
Ross, Stephen Mr. Stephen Ross is Director, Secretary and Chief Financial Officer of Remedent, Inc. Mr. Ross has served as director since August 2001 and as Secretary since April 2002. He also served as Chief Financial Officer from August 2001 until March 2005. He was recently reappointed as Chief Financial Officer, effective December 18, 2008. From February 1998 through January 2001, Mr. Ross was CFO of Dental & Medical Diagnostic Systems, Inc., a company that developed and marketed high-tech dental equipment and declared bankruptcy in July 2001. Commencing in 1996 and terminating February 1998, Mr. Ross served as a senior management consultant with Kibel and Green, a corporate restructuring and management firm. Prior to working for Kibel and Green, Mr. Ross served as CFO and co-founder of a personal care company, and as tax manager with an accounting firm. Mr. Ross resides in Los Angeles, California.
Van Acker, Philippe Mr. Philippe Van Acker is Chief Accounting Officer, Director of Remedent, Inc. Mr. Van Acker was appointed as Chief Financial Officer as of March 30, 2005. Effective December 18, 2008, Mr. Van Acker resigned as Chief Financial Officer and became Chief Accounting Officer as well as assuming a position on the Board of Directors. From July 2001 to March 30, 2005, Mr. Van Acker has served as a director of subsidiary, Remedent N.V. where he has also served as financial controller. From 1999 to 2001, Mr. Van Acker served as Director of Finance for DMDS, Ltd., a European subsidiary of Dental & Medical Diagnostic Systems, Inc., a company that developed and marketed high-tech dental equipment. From 1992 to 1999, Mr. Van Acker held various positions with Pfizer Medical Technology Group. Mr. Van Acker resides in Belgium.
Kolsteeg, Fred Mr. Fred Kolsteeg is Director of Remedent, Inc. Since 1996, Mr. Kolsteeg has served as the president of WAVE Communications, a Dutch based advertising agency. Prior to founding WAVE in 1996, he founded several other advertising agencies such as ARA, Team and Team Saatchi. Mr. Kolsteeg has also worked at Phillips and Intermarco Publicis. Mr. Kolsteeg resides in Holland.

Basic Compensation

Name Fiscal Year Total
De Vreese, Guy 318,490
Ross, Stephen 98,844
Van Acker, Philippe 211,964
Kolsteeg, Fred --
As Of 30 Mar 2009

Options Compensation

Name Options Value
De Vreese, Guy 0 0
Ross, Stephen 0 0
Van Acker, Philippe 0 0
Kolsteeg, Fred 0 0

Insider Trading

Name Shares Traded Price
GRUBER & MCBAINE CAPITAL MANAGEMENT L L 1,400 $0.38
GRUBER & MCBAINE CAPITAL MANAGEMENT L L 7,200 $0.38
GRUBER & MCBAINE CAPITAL MANAGEMENT L L 1,400 $0.38
ROSS STEPHEN FARLEY 100 $0.52
ROSS STEPHEN FARLEY 100 $0.65
ROSS STEPHEN FARLEY 200 $0.75
ROSS STEPHEN FARLEY 150 $0.90
ROSS STEPHEN FARLEY 2,000 $0.40
ROSS STEPHEN FARLEY 5,000 $0.45
LIST ROBIN 723,000 $0.00
LEDDINGTON ROGER 2,000 $1.14
» Full list on Insider Trading
view people for: